Evidence mapPaperPMID 41373440Full record

ReviewInternational journal of molecular sciences2025

Targeting Lactylation for Cancer: Mechanisms, Effects, and Therapeutic Prospects.

Dong Chang, Daolong Li, Yuxi Sun, Jiekang Shi, Shengping Zhang, Chuangui Wang

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dong ChangBiomedical Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255000, China.ORCID 0000-0002-2106-6581
Daolong LiBiomedical Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255000, China.
Yuxi SunBiomedical Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255000, China.
Jiekang ShiBiomedical Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255000, China.
Shengping ZhangBiomedical Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255000, China.
Chuangui WangBiomedical Research Institute, School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255000, China.

Funding

National Natural Science Foundation of China 32170707, 32170784
6 · The paper itself

Abstract

Recent studies reveal that lysine lactylation plays a pivotal and multifaceted role in tumor progression. Here, we provide a systematic overview of the mechanisms underlying lactylation, highlighting its regulation of tumor metabolic reprogramming and immune microenvironment remodeling. We further summarize how lactylation drives malignancy across diverse cancer types and discuss emerging strategies to therapeutically target lactylation in cancer. By integrating current findings, this review offers a comprehensive framework for understanding lactylation in tumor biology and identifies key gaps for future investigation, thereby providing a valuable reference for both basic research and therapeutic development.

Indexed as

LysineNeoplasmsProtein Processing, Post-TranslationalAnimalsHumansTumor MicroenvironmentLysineimmune microenvironmentlactatelactylationmetabolictumor

Identifiers

PMID41373440
PMCPMC12692379

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.